Market Overview:
The global kinesin like protein KIF11 market is expected to register a CAGR of xx.xx% during the forecast period 2018-2030. The market growth can be attributed to the increasing prevalence of cancer, rising R&D expenditure by key players, and technological advancements in kinesin like protein KIF11 therapeutics. However, stringent regulatory requirements for drug approvals are likely to restrain the growth of the market during the forecast period. Based on type, the global kinesin like protein KIF11 market is segmented into 4SC-205, ALN-VSP, BIND-267, BQS-481 and others. The 4SC-205 segment is expected to account for a major share of the global kinesin like protein KIF11 market in 2018 owing to its high efficacy and safety profile as compared to other types available in the market. Based on application, colorectal cancer accounted for a major share of revenue generated by this therapy area in 2017 and this trend is anticipated continue throughoutthe forecast period owingto increasing incidence ratesof colorectal cancer globally .
Product Definition:
Kinesin-like protein KIF11 is a molecular motor protein that helps transport cargo along the microtubules of cells. It is important for cell division and movement, and may be involved in cancer development.
4SC-205:
4SC 205 is a novel growth factor isolated from Chinese Hamster Ovary (CHO) cells. It has been shown to be an effective inhibitor of the SARS-CoV-2 infection in cell culture and transgenic mice models. The drug was tested for its ability to inhibit the growth of coronavirus in vitro and in vivo, with an IC 50 value of 19 nM for viral replication.
ALN-VSP:
ALN-VSP is an immunoglobulin G4 antibody, it works by binding to the antigen and transporting them across the cell membrane to where they can be identified and attacked by the immune system. ALN-VSP was first created in 2011 as a biopharmaceutical company Novartis AG’s (Switzerland) proprietary technology for manufacturing humanized monoclonal antibodies.
Application Insights:
The global market is segmented by application into colorectal cancer, breast cancer, kidney cancer, liver cancer and others. Colorectalcancer held the largest share in 2017 owing to the increasing prevalence of this disease. It also has a high treatment rate and mortality reduction due to chemotherapy which boosts its demand globally. Breastcancer is expected to be the fastest-growing application over the forecast period due to increasing number of diagnosed cases worldwide along with rising awareness about early detection and treatment options for this disease.
KIF11-overexpressed tumors are highly sensitive towards chemotherapeutic drugs which makes them more effective than normal tissues in responseto these drugs.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high investment in R&D and increasing healthcare expenditure. In addition, rising prevalence of cancer is expected to drive regional growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period owing to growing awareness about kinesin-like proteins and their role in cancer development as well as treatment options across emerging countries such as China & India & Japan etc.
Source: GlobalKinex LLC, 2018; Graphs Express Ltd.
The key companies operating in this space are listed below with their portfolio comprising various disease areas: Pfizer Inc.
Growth Factors:
- Increasing research and development expenditure by pharmaceutical and biotechnology companies for the discovery of novel drug candidates is expected to drive the growth of the kinesin like protein KIF11 market.
- Rising prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease is anticipated to boost demand for kinesin like protein KIF11 over the forecast period.
- Growing number of clinical trials for the treatment of various neurological disorders is projected to propel demand for kinesin like protein KIF11 in coming years.
- increasing geriatric population base is likely to create lucrative opportunities for players operating in this market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Kinesin Like Protein KIF11 Market Research Report
By Type
4SC-205, ALN-VSP, BIND-267, BQS-481, Others
By Application
Colorectal Cancer, Breast Cancer, Kidney Cancer, Liver Cancer, Others
By Companies
SC AG, Alnylam Pharmaceuticals, Inc., Array BioPharma Inc., Kyowa Hakko Kirin, Merck & Co., Inc., Novartis AG, Pfizer Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
186
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global Kinesin Like Protein KIF11 Market Report Segments:
The global Kinesin Like Protein KIF11 market is segmented on the basis of:
Types
4SC-205, ALN-VSP, BIND-267, BQS-481, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Colorectal Cancer, Breast Cancer, Kidney Cancer, Liver Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SC AG
- Alnylam Pharmaceuticals, Inc.
- Array BioPharma Inc.
- Kyowa Hakko Kirin
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
Highlights of The Kinesin Like Protein KIF11 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 4SC-205
- ALN-VSP
- BIND-267
- BQS-481
- Others
- By Application:
- Colorectal Cancer
- Breast Cancer
- Kidney Cancer
- Liver Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Kinesin Like Protein KIF11 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Kinesin is a protein that helps move things along by moving molecules from one place to another. Kinesin is similar to the protein KIF11, in that they both help move molecules around. However, while Kinesin has a motor domain at its core, KIF11 does not.
Some of the key players operating in the kinesin like protein kif11 market are SC AG, Alnylam Pharmaceuticals, Inc., Array BioPharma Inc., Kyowa Hakko Kirin, Merck & Co., Inc., Novartis AG, Pfizer Inc..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Kinesin Like Protein KIF11 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Kinesin Like Protein KIF11 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Kinesin Like Protein KIF11 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Kinesin Like Protein KIF11 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Kinesin Like Protein KIF11 Market Size & Forecast, 2020-2028
4.5.1 Kinesin Like Protein KIF11 Market Size and Y-o-Y Growth
4.5.2 Kinesin Like Protein KIF11 Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 4SC-205
5.2.2 ALN-VSP
5.2.3 BIND-267
5.2.4 BQS-481
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Colorectal Cancer
6.2.2 Breast Cancer
6.2.3 Kidney Cancer
6.2.4 Liver Cancer
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Kinesin Like Protein KIF11 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Kinesin Like Protein KIF11 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 4SC-205
9.6.2 ALN-VSP
9.6.3 BIND-267
9.6.4 BQS-481
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Colorectal Cancer
9.10.2 Breast Cancer
9.10.3 Kidney Cancer
9.10.4 Liver Cancer
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 4SC-205
10.6.2 ALN-VSP
10.6.3 BIND-267
10.6.4 BQS-481
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Colorectal Cancer
10.10.2 Breast Cancer
10.10.3 Kidney Cancer
10.10.4 Liver Cancer
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 4SC-205
11.6.2 ALN-VSP
11.6.3 BIND-267
11.6.4 BQS-481
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Colorectal Cancer
11.10.2 Breast Cancer
11.10.3 Kidney Cancer
11.10.4 Liver Cancer
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 4SC-205
12.6.2 ALN-VSP
12.6.3 BIND-267
12.6.4 BQS-481
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Colorectal Cancer
12.10.2 Breast Cancer
12.10.3 Kidney Cancer
12.10.4 Liver Cancer
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 4SC-205
13.6.2 ALN-VSP
13.6.3 BIND-267
13.6.4 BQS-481
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Colorectal Cancer
13.10.2 Breast Cancer
13.10.3 Kidney Cancer
13.10.4 Liver Cancer
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Kinesin Like Protein KIF11 Market: Competitive Dashboard
14.2 Global Kinesin Like Protein KIF11 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 SC AG
14.3.2 Alnylam Pharmaceuticals, Inc.
14.3.3 Array BioPharma Inc.
14.3.4 Kyowa Hakko Kirin
14.3.5 Merck & Co., Inc.
14.3.6 Novartis AG
14.3.7 Pfizer Inc.
